Por: ABC News Health March 14, 2023
Novo Nordisk will start slashing some U.S. insulin prices up to 75% next year, following a path set earlier this month by rival Eli Lilly. The Danish drugmaker said Tuesday that pre-filled pens and vials of long-acting and short-acting insulins will see price reductions. They include Levemir, Novolin, NovoLog and NovoLog Mix70/30. Novo also will drop the list price of some unbranded products to match the lower price of the branded insulins.The... + full article
The Atlantic USA Opinion October 16, 2023
Can Novo Nordisk’s success really be a problem for the Danish economy?Ben Kothe / The Atlantic; GettyOctober 16, 2023, 7:30 AM ETOver the past couple of years, no new pharmaceutical drug—perhaps no product, period—has had such widespread impact as the diabetes medication... + más
What Are the Duties of A Trustee? | Forbes
Rare silver coin from first Jewish revolt against Roman Empire discovered | Newsweek
MarketWatch USA Business August 08, 2023
The positive results represent the first concrete evidence that the new class of weight-loss drugs from Novo Nordisk (ticker: NVO) and Eli Lilly (LLY) offer substantive health benefits beyond weight reduction for overweight or obese patients without diabetes. The results will... + más
The End Of Obesity | Forbes
Use medication, surgery early to treat obesity in kids, new guidance says | Portland Press Herald
ABC7 USA Health March 17, 2023
Sanofi is cutting the list price of Lantus, its most widely prescribed insulin in the US, by 78% and establishing a $35 monthly cap for those with private insurance, the company announced Thursday. The change is effective January 1.The move follows similar ones by Eli Lilly and... + más
Sanofi is the latest insulin maker to announce price cap | WPTV
Sanofi Cuts Insulin Prices Up To 78%—Following Eli Lilly And Novo Nordisk | Forbes
Forbes USA Business March 14, 2023
Topline Pharmaceutical heavyweight Novo Nordisk on Tuesday it is cutting prices for several insulin drugs in the U.S., following a similar move from drugmaker Eli Lilly as healthcare companies come under increasing pressure to lower prices for the lifesaving diabetes medication.... + más
Novo Nordisk to lower insulin prices by 75% | Fox Business
Novo Nordisk to slash U.S. insulin prices by up to 75%, following move by Eli Lilly | CNBC
Orlando Sentinel USA Business March 14, 2023
Novo Nordisk will start slashing some U.S. insulin prices up to 75% next year, following a path set earlier this month by rival Eli Lilly. The Danish drugmaker said Tuesday that pre-filled pens and vials of long- and short-acting insulins will see list price reductions. They... + más
Novo Nordisk Will Lower Insulin Prices Up To 75%, Following Eli Lilly | Forbes
Associated Press USA Health March 14, 2023
CNBC USA Health March 14, 2023
In this articleNovo Nordisk Inc. NovoLog brand insulin pens are arranged for a photograph in the Brooklyn borough of New York, U.S., on Friday, April 5, 2019.Alex Flynn Bloomberg Getty Images on Tuesday announced plans to slash the price of several insulin drugs by up to 75% in... + más
About iurex | Privacy Policy | Disclaimer |